These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21274701)

  • 1. S 18986 reverses spatial working memory impairments in aged mice: comparison with memantine.
    Vandesquille M; Krazem A; Louis C; Lestage P; Béracochéa D
    Psychopharmacology (Berl); 2011 Jun; 215(4):709-20. PubMed ID: 21274701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic enhancing-memory effect of donepezil and S 47445, an AMPA positive allosteric modulator, in middle-aged and aged mice.
    Bretin S; Krazem A; Henkous N; Froger-Colleaux C; Mocaer E; Louis C; Perdaems N; Marighetto A; Beracochea D
    Psychopharmacology (Berl); 2018 Mar; 235(3):771-787. PubMed ID: 29167913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMPA modulator S 18986 improves declarative and working memory performances in aged mice.
    Marighetto A; Valerio S; Jaffard R; Mormede C; Muñoz C; Bernard K; Morain P
    Behav Pharmacol; 2008 May; 19(3):235-44. PubMed ID: 18469541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of NMDA receptor antagonist, memantine, against senescence of PC12 cells: A possible role of nNOS and combined effects with donepezil.
    Ota H; Ogawa S; Ouchi Y; Akishita M
    Exp Gerontol; 2015 Dec; 72():109-16. PubMed ID: 26408226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine, an NMDA receptor antagonist, improves working memory deficits in DGKβ knockout mice.
    Kakefuda K; Ishisaka M; Tsuruma K; Shimazawa M; Hara H
    Neurosci Lett; 2016 Sep; 630():228-232. PubMed ID: 27495014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of positive modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors in a benzodiazepine-induced deficit of spatial discrimination in mice.
    Vandesquille M; Carrié I; Louis C; Beracochea D; Lestage P
    J Psychopharmacol; 2012 Jun; 26(6):845-56. PubMed ID: 21890586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant manipulation of murine NMDA- and AMPA-receptors to produce pro-cognitive drug effects in mice.
    Vignisse J; Steinbusch HW; Grigoriev V; Bolkunov A; Proshin A; Bettendorff L; Bachurin S; Strekalova T
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):309-20. PubMed ID: 23993168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive improvement by acute growth hormone is mediated by NMDA and AMPA receptors and MEK pathway.
    Ramis M; Sarubbo F; Sola J; Aparicio S; Garau C; Miralles A; Esteban S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():11-20. PubMed ID: 23590874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus.
    Tarragon E; Lopez D; Estrada C; Gonzalez-Cuello A; Ros CM; Lamberty Y; Pifferi F; Cella M; Canovi M; Guiso G; Gobbi M; Fernández-Villalba E; Blin O; Bordet R; Richardson JC; Herrero MT
    Neuropharmacology; 2014 Oct; 85():206-14. PubMed ID: 24878242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine can improve chronic ethanol exposure-induced spatial memory impairment in male C57BL/6 mice by reducing hippocampal apoptosis.
    Wang X; Yu H; You J; Wang C; Feng C; Liu Z; Li Y; Wei R; Xu S; Zhao R; Wu X; Zhang G
    Toxicology; 2018 Aug; 406-407():21-32. PubMed ID: 29800586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-801 and memantine act differently on short-term memory tested with different time-intervals in the Morris water maze test.
    Duda W; Wesierska M; Ostaszewski P; Vales K; Nekovarova T; Stuchlik A
    Behav Brain Res; 2016 Sep; 311():15-23. PubMed ID: 27180167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of hippocampal markers of synaptic plasticity by memantine in animal models of acute and repeated restraint stress: implications for memory and behavior.
    Amin SN; El-Aidi AA; Ali MM; Attia YM; Rashed LA
    Neuromolecular Med; 2015 Jun; 17(2):121-36. PubMed ID: 25680935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats.
    Pietá Dias C; Martins de Lima MN; Presti-Torres J; Dornelles A; Garcia VA; Siciliani Scalco F; Rewsaat Guimarães M; Constantino L; Budni P; Dal-Pizzol F; Schröder N
    Neuroscience; 2007 Jun; 146(4):1719-25. PubMed ID: 17445991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer's disease transgenic model.
    Chen TF; Huang RF; Lin SE; Lu JF; Tang MC; Chiu MJ
    J Alzheimers Dis; 2010; 20(2):607-15. PubMed ID: 20164552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous and discrete T-maze alternation in rats: effects of intertrial and interrun intervals.
    Brito LS; Yamasaki EN; Paumgartten FJ; Brito GN
    Braz J Med Biol Res; 1987; 20(1):125-35. PubMed ID: 3690044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine: a therapeutic approach in treating Alzheimer's and vascular dementia.
    Koch HJ; Uyanik G; Fischer-Barnicol D
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):499-506. PubMed ID: 16266284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive benefits of memantine in Alzheimer's 5XFAD model mice decline during advanced disease stages.
    Devi L; Ohno M
    Pharmacol Biochem Behav; 2016 May; 144():60-6. PubMed ID: 26948858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease.
    Filali M; Lalonde R; Rivest S
    Neuropharmacology; 2011 May; 60(6):930-6. PubMed ID: 21281652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.